This site is intended for healthcare professionals only

PCRA Logo

Update: Management of co-morbidities in asthma

Posted on: 31 Mar 2017
 

Module summary

This module will highlight the importance of the early recognition of comorbidities in patients with asthma.

Learning objectives

After completing the module, you should be able to:

  • Describe the major comorbidities associated with asthma
  • List common tests to identify and assess comorbidities
  • Discuss how comorbidities can contribute to the pathogenesis and poor control of asthma
  • Communicate the benefits of diagnosing and treating comorbidities in overall asthma management
  • Define the key principles of treating difficult asthma, for instance when to make a specialist referral

Introduction

Patients with asthma often present with various comorbidities which can lead to poorer outcomes of their condition, through factors such as a misdiagnosis or misinterpretation of symptoms, and this can complicate management.1-3

For example, symptoms such as increased breathlessness may be misattributed to a patient’s asthma when they are, in fact, caused by a coexistent condition such as chronic obstructive pulmonary disease (COPD). Some comorbid conditions can alter the phenotype, or the way in which asthma presents, making it harder to diagnose. For example, the coexistence of nasal polyps in asthmatics has been linked with aspirin intolerance and a more severe asthma phenotype.1 A misdiagnosis may also occur if a patient has a coexistent condition, e.g. a psychological morbidity which causes them to incorrectly perceive their asthmatic symptoms. Clearly, the failure to correctly diagnose comorbidities can result in the inappropriate management of a patient’s asthma.1,3-5

The prevalence of comorbidities may be higher in difficult asthma, a subgroup of patients defined by the BTS/SIGN 2016 asthma guideline as having persistent symptoms and/or frequent asthma attacks despite treatment with high-dose therapies or continuous or frequent use of oral steroids.6

Difficult asthma can greatly affect a patient’s quality of life. Patients experience frequent exacerbations that can result in many days of absence from work or school. Difficult asthma increases the likelihood of hospital admission by 20 times and accounts for 50% of asthma-related expenditure in the United Kingdom.5,7

Recognising the role of comorbidities in difficult asthma, the BTS/SIGN 2016 asthma guideline recommends checking for such conditions as part of the evaluation process in a patient with difficult asthma.6

List of abbreviations
ACO Asthma–COPD overlap ICS Inhaled corticosteroid
BMI Body mass index LAMA Long-acting muscarinic antagonist
BTS/SIGN British Thoracic Society/ Scottish Intercollegiate Guidelines Network OSA Obstructive sleep apnoea
COPD Chronic obstructive pulmonary disease PEF Peak expiratory flow
CT Computed topography PPI Proton pump inhibitor
ECG Electrocardiogram RCPH Royal College of Paediatrics and Child Health
FEV1 Forced expiratory volume in 1 second SABA Short-acting beta agonist
GINA Global Initiative for Asthma TLCO Transfer factor for carbon monoxide
GORD Gastro-oesophageal reflux disease

Log in

To access these modules, you will need to register for a free account. After registering, you'll be able to:

  • Complete the module and access your certificate
  • Save your progress in a module and come back later, if you don't want to complete it in one sitting
  • Revisit your completed modules anytime to refresh your memory and reflect on what you have learned

Media partners


The Primary Care Respiratory Academy has been developed and is produced by Cogora, the publisher of Pulse, Nursing in Practice, Healthcare Leader, Management in Practice and The Pharmacist working in partnership with PCRS. All educational content for the website and Roadshows, unless specified as sponsored content, has been initiated and produced by PCRS/Cogora.